| 4KJY: reference: Engineered SIRPalpha variants as immunotherapeutic adjuvants to anticancer antibodies., Weiskopf K, Ring AM, Ho CC, Volkmer JP, Levin AM, Volkmer AK, Ozkan E, Fernhoff NB, van de Rijn M, Weissman IL, Garcia KC, Science. 2013 Jul 5;341(6141):88-91. doi: 10.1126/science.1238856. Epub 2013 May , 30. PMID: 23722425 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).